Does common genetic variation at TRIB1 increase triglycerides and apoB-containing lipoproteins?

Clinical evidence and genetic associations

• Genetic risk alleles and lipid profiles: Genome-wide association studies (GWAS) involving over 100,000 individuals consistently link common genetic variation at the TRIB1 locus—specifically the risk allele (A) of the tag single nucleotide polymorphism (SNP) rs2954029—with elevated plasma triglycerides and apolipoprotein B (apoB) levels. Each copy of the risk allele is associated with a standard deviation increase of approximately 0.03 to 0.06 in plasma triglyceride concentrations.
• Atherogenic particle burden: Because every very-low-density lipoprotein (VLDL) and low-density lipoprotein (LDL) particle contains exactly one apoB molecule, the elevated apoB levels reflect an increased concentration of atherogenic, circulating lipoprotein particles. Multivariable Mendelian randomization analyses indicate that the cardiovascular risk associated with the TRIB1 locus is mediated primarily by this increased apoB particle burden.

Mechanistic explanations

• C/EBPα stabilization and de novo lipogenesis: TRIB1 encodes a pseudokinase that acts as an adapter, recruiting the COP1 E3 ubiquitin ligase to target transcription factors for proteasomal degradation. In hepatocytes, TRIB1 typically targets CCAAT/enhancer-binding protein alpha (C/EBPα) for degradation.
• Lipoprotein assembly and secretion: When TRIB1 function is genetically compromised, C/EBPα is stabilized. Elevated C/EBPα upregulates the transcription of lipogenic genes, boosting de novo lipogenesis and expanding the intracellular pool of triglycerides. This excess triglyceride pool fuels the assembly and secretion of VLDL particles in the liver.
• Dual clearance defect: In addition to driving VLDL overproduction, TRIB1 deficiency modulates the low-density lipoprotein receptor (LDLR) pathway. Decreased TRIB1 activity downregulates LDLR expression on hepatocytes, which impairs the clearance of circulating LDL-apoB particles and compounds systemic hyperlipidemia.

Bottom line

Common genetic variation at the TRIB1 locus (specifically rs2954029) is robustly associated with elevated triglycerides and apoB-containing lipoproteins. This phenotype is driven by a hepatic lipoprotein overproduction bias combined with reduced particle clearance, mediated through C/EBPα stabilization, increased lipogenesis, and decreased hepatocyte LDLR expression.